Decoding BBWI Stock – A Comprehensive Market Analysis

Bath & Body Works logged a -1.7% change during today's afternoon session, and is now trading at a price of $38.41 per share. The S&P 500 index moved 0.0%. BBWI's trading volume is 1,292,601 compared to the stock's average volume of 2,917,985.

Bath & Body Works trades -26.51% away from its average analyst target price of $52.26 per share. The 18 analysts following the stock have set target prices ranging from $42.0 to $65.0, and on average have given Bath & Body Works a rating of buy.

Anyone interested in buying BBWI should be aware of the facts below:

  • Bath & Body Works has moved 3.0% over the last year, and the S&P 500 logged a change of 22.6%

  • Based on its trailing earnings per share of 3.87, Bath & Body Works has a trailing 12 month Price to Earnings (P/E) ratio of 9.9 while the S&P 500 average is 27.65

  • BBWI has a forward P/E ratio of 10.2 based on its forward 12 month price to earnings (EPS) of $3.75 per share

  • The company has a price to earnings growth (PEG) ratio of 2.36 — a number near or below 1 signifying that Bath & Body Works is fairly valued compared to its estimated growth potential

  • Bath & Body Works, Inc. operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products.

  • Based in Columbus, the company has 8,981 full time employees and a market cap of $8.57 Billion. Bath & Body Works currently returns an annual dividend yield of 2.0%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.